DSS, INC. sold 723 shares of IMPACT BIOMEDICAL INC. at $0.55 for −$398 on Sep 22, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
10% owner
10%
Filed Sep 24, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$397.65Shares × reported price
Shares traded
723Common Stock
Price per share
$0.55Reported price. Read footnotes for ranges.
% of reported position traded
0.12%This security and ownership context
Holdings after
589,701Direct
Trade date
Sep 22, 2026Sell
Filed
Sep 24, 2026, 7:37 PM ET2-day reporting delay
Accession
0001493152-26-044207Code S · Transaction 229364
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 590,424 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 23, 2026Sell27$6.95−$187.65Trade 229365
Sep 24, 2026Sell156$7.06−$1,101.16Trade 229366
3 transaction rows in this filing. Joint filers share the same rows.

IBO price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
IBO · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Oct 1, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Footnotes in full

No footnotes recorded. Check the original SEC filing for the complete report.